Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.

With the use of microarray gene-expression profiling, we analyzed a homogeneous series of 32 patients with systemic anaplastic large-cell lymphoma (ALCL) and 5 ALCL cell lines. Unsupervised analysis classified ALCL in 2 clusters, corresponding essentially to morphologic subgroups (ie, common type vs small cell and "mixed" variants) and clinical variables. Patients with a morphologic variant of ALCL had advanced-stage disease. This group included a significant number of patients who experienced early relapse. Supervised analysis showed that ALK+ALCL and ALK- ALCL have different gene-expression profiles, further confirming that they are different entities. Among the most significantly differentially expressed genes between ALK+ and ALK- samples, we found BCL6, PTPN12, CEBPB, and SERPINA1 genes to be overexpressed in ALK+ ALCL. This result was confirmed at the protein level for BCL-6, C/EBPbeta and serpinA1 through tissue microarrays. The molecular signature of ALK- ALCL included overexpression of CCR7, CNTFR, IL22, and IL21 genes but did not provide any obvious clues to the molecular mechanism underlying this tumor subtype. Once confirmed on a larger number of patients, the results of the present study could be used for clinical and therapeutic management of patients at the time of diagnosis.

[1]  G. Delsol,et al.  SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling. , 2006, Blood.

[2]  C. Copie-Bergman,et al.  Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL): A New Diagnostic Marker Providing Evidence That AITL Derives From Follicular Helper T Cells , 2006, The American journal of surgical pathology.

[3]  P. Gaulard,et al.  Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas , 2006, Oncogene.

[4]  Walter Birchmeier,et al.  Balancing cell adhesion and Wnt signaling, the key role of β-catenin , 2006 .

[5]  J. Benítez,et al.  Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas , 2005, Leukemia.

[6]  B. Dörken,et al.  A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. , 2005, Blood.

[7]  A. Rosenwald,et al.  Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. , 2005, Human pathology.

[8]  R. Fonseca,et al.  Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis. , 2005, Blood.

[9]  K. Pulford,et al.  The emerging normal and disease-related roles of anaplastic lymphoma kinase. , 2004, Cellular and molecular life sciences : CMLS.

[10]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[11]  B. Bapat,et al.  Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of β-catenin and TCF/LEF-mediated transcriptional activation , 2004, Oncogene.

[12]  R. Gascoyne,et al.  Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a ‘small-cell variant’ of ALCL , 2004, Leukemia.

[13]  Pingping Shen,et al.  NF-kappaB and its regulation on the immune system. , 2004, Cellular & molecular immunology.

[14]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[15]  J. Benítez,et al.  Expression Profiling of T-Cell Lymphomas Differentiates Peripheral and Lymphoblastic Lymphomas and Defines Survival Related Genes , 2004, Clinical Cancer Research.

[16]  Joaquín Dopazo,et al.  FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes , 2004, Bioinform..

[17]  K. Basso,et al.  Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors , 2004, The Journal of experimental medicine.

[18]  A. Rosenwald.  DNA microarrays in lymphoid malignancies. , 2003, Oncology.

[19]  L. Staudt,et al.  Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma , 2003, The Journal of experimental medicine.

[20]  Adrian Wiestner,et al.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Gascoyne,et al.  Non‐muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma , 2003, Genes, chromosomes & cancer.

[22]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[23]  Yoav Benjamini,et al.  Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..

[24]  P. Trempat,et al.  Isolation of differentially expressed genes in NPM‐ALK‐positive anaplastic large cell lymphoma , 2002, British journal of haematology.

[25]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[26]  K. Elenitoba-Johnson,et al.  Gene expression profiling of cell lines derived from T‐cell malignancies , 2002, FEBS letters.

[27]  Meland,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[28]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[29]  F. Gudat,et al.  Alterations on the 5′ Noncoding Region of the BCL-6 Gene Are Not Correlated with BCL-6 Protein Expression in T Cell Non-Hodgkin Lymphomas , 2001, Laboratory Investigation.

[30]  S. McKnight.  McBindall—A Better Name for CCAAT/Enhancer Binding Proteins? , 2001, Cell.

[31]  F. McCormick,et al.  Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. , 2001, Cancer research.

[32]  P. Brown,et al.  Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. , 2001, The American journal of pathology.

[33]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[34]  S. Pileri,et al.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. , 2000, Blood.

[35]  S. Goff,et al.  Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. , 2000, Molecular cell.

[36]  L. Staudt,et al.  BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. , 2000, Immunity.

[37]  E. Jaffe,et al.  Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. , 2000, Blood.

[38]  M. Ladanyi,et al.  ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). , 2000, The American journal of pathology.

[39]  A. Kikuchi.  Regulation of β-Catenin Signaling in the Wnt Pathway , 2000 .

[40]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[41]  T. Greiner,et al.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. , 1999, Blood.

[42]  K. Pulford,et al.  A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. , 1999, Blood.

[43]  S. Pileri,et al.  ALK-positive lymphoma: a single disease with a broad spectrum of morphology. , 1998, Blood.

[44]  B. Falini,et al.  BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas , 1997 .

[45]  R. Bertorelle,et al.  A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease. , 1994, Leukemia.

[46]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[47]  K Offit,et al.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.

[48]  M. Toyota,et al.  Cloning and characterization of a human cDNA encoding a novel putative cytoplasmic protein-tyrosine-phosphatase. , 1992, Biochemical and biophysical research communications.

[49]  E. Hachulla,et al.  Comparison of the effects of purified human alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor on NK cytotoxicity: only alpha 1-proteinase inhibitor inhibits natural killing. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[50]  C. Farnarier,et al.  Changes in serum level and affinity for concanavalin A of human alpha 1-proteinase inhibitor in severe burn patients: relationship to natural killer cell activity. , 1989, Biochimica et biophysica acta.

[51]  J. Travis,et al.  Serum α-1 Proteinase Inhibitor in Advanced Cancer: Mass Variants and Functionally Inert Forms , 1987 .

[52]  K. Lennert,et al.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.

[53]  H. Stein,et al.  MALIGNANT HISTIOCYTOSIS OF THE INTESTINE: A T-CELL LYMPHOMA , 1985, The Lancet.

[54]  T. Ikuta,et al.  Influence of acute-phase proteins on the activity of natural killer cells , 1985, Inflammation.

[55]  P. Kilbridge,et al.  Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Robinson,et al.  Comparison of phylogenetic trees , 1981 .

[57]  P. Isaacson,et al.  Malignant histiocytosis of the intestine. Its relationship to malabsorption and ulcerative jejunitis. , 1978, Human pathology.

[58]  A. Epstein,et al.  Biology of the human malignant lymphomas I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas , 1974, Cancer.

[59]  A. Primack,et al.  Elevated alpha1‐antitrypsin serum levels in lung cancer patients , 1974, Cancer.

[60]  Walter Birchmeier,et al.  Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. , 2006, Current opinion in genetics & development.

[61]  Pingping Shen,et al.  NF-κB and Its Regulation on the Immune System , 2004 .

[62]  S. Dragon,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use only. , 2002 .

[63]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[64]  H. Clevers,et al.  The Yin-Yang of TCF/beta-catenin signaling. , 2000, Advances in cancer research.

[65]  A. Kikuchi.  Regulation of beta-catenin signaling in the Wnt pathway. , 2000, Biochemical and biophysical research communications.

[66]  G. Leverger,et al.  Anaplastic Large-Cell Lymphoma in Children : Analysis of 82 Patients Enrolled in Two Consecutive Studies of the French Society of Pediatric Oncology , 1998 .

[67]  B. Falini,et al.  BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas. , 1997, Blood.

[68]  P. Sherrington,et al.  A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. , 1988, Blood.

[69]  J. Travis,et al.  Serum alpha-1 proteinase inhibitor in advanced cancer: mass variants and functionally inert forms. , 1987, Cancer research.